Low-Level Laser Therapy (LLLT) for Hair Growth: How Laser Caps Work - NovaClin Labs

LLLT Hair Growth Caps: Model Identity and Specifications

When reviewing an LLLT hair-growth cap, start with the exact product. A familiar configuration number, red-light appearance or broad category description does not establish that two devices are the same.

For clinic buyers, a clear review connects the product label, specification sheet, instructions and supporting documents.

What the current NovaClin listing describes

The NovaClin Labs LLLT cap listing describes a 128-laser-diode cap with a 650 nm wavelength and a stated output of 5 mW per diode. These are listed configuration details, not a complete measurement of scalp exposure or a clinical result.

Confirm the manufacturer and exact model supplied with the order. Keep the model reference with any technical or performance document used in your review.

Read regulatory documents against the named device

The FDA document K253231 names a Laser Hair Growth System submitted by Hubei YJT Technology Co., Ltd. Its listed configurations include Laser Cap 128 and several Laser Helmet models.

That document should not be used to identify another branded product solely because a configuration number matches. A regulatory statement needs documentation connecting the supplied product to the exact named device and applicable scope.

Keep evidence and instructions specific

When a paper or report is supplied, record which device it evaluates and which question it addresses. A technical measurement, a regulatory record and a clinical outcome report should remain distinguishable in the review.

Do not transfer treatment times or schedules from another model. Clinical suitability and use require individual assessment and the instructions for the actual supplied device.

Read clinical evidence against the device studied

A multicentre, randomised, sham-controlled study published in 2014 evaluated specific HairMax Lasercomb models in men and women with pattern hair loss. The trial reported a greater increase in terminal hair density with the studied lasercomb devices than with sham devices over 26 weeks.

That result concerns the models and trial population studied. It does not establish the clinical performance of NovaCap caps or helmets, and its schedule should not be transferred to a different device.

Jimenez JJ et al. Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study. American Journal of Clinical Dermatology. 2014;15(2):115–127.

Prepare a professional enquiry

Include the exact model being considered, the requested quantity and the documents your clinical team wishes to review. Ask for clarification where the product name or specification differs between the quotation and a supporting document.

Contact NovaClin Labs to enquire about the listed cap and its documentation. This overview does not promise hair regrowth or establish a treatment schedule.

NovaClin Labs. Quietly Clinical.

Back to blog